SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : INCR -- Incara Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (187)2/19/2003 11:54:27 AM
From: Micawber  Respond to of 196
 
From the Proxy:

The Board believes that the increase number of authorized shares of common stock will provide several long-term advantages to Incara and its stockholders. Incara will be able to pursue acquisitions or enter into other transactions involving the issuance of stock that provide for future capital and growth.

Nice to see a nickel stock with a $750,000 MC and negative BV is still on the prowl. The mouse roars.

BPG